ICBB 2024 - 2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
Date2024-03-29 - 2024-03-31
Deadline2024-03-27
VenueWuhan, China
KeywordsBiotechnology; Biomedicine
Websitehttps://ais.cn/u/Fzeqau
Topics/Call fo Papers
The 6th International Conference on Biotechnology and Biomedicine (ICBB 2024) will be held in Wuhan, China from March 29 to 31, 2024.
Important Dates:
Full Paper Submission Date: December 29, 2023
Registration Deadline: March 19, 2024
Final Paper Submission Date: March 27, 2024
Conference Dates: March 29-31, 2024
---Call For Papers---
The topics of interest for submission include, but are not limited to:
1.Biotechnology
- CRISPR/Cas9 genome editing technology
- Plant biotechnology and its potential applications
- Synthetic biology: designing and creating new biological systems ...
2.Biomedicine
- Advances in precision medicine
- Novel therapeutic targets and drug development
- Genetic basis of disease and personalized treatment ...
All accepted full papers will be published by BIO Web of Conferences (ISSN: 2117-4458) and will be submitted to Scopus for indexing.
For More Details please visit:
https://ais.cn/u/Fzeqau
Important Dates:
Full Paper Submission Date: December 29, 2023
Registration Deadline: March 19, 2024
Final Paper Submission Date: March 27, 2024
Conference Dates: March 29-31, 2024
---Call For Papers---
The topics of interest for submission include, but are not limited to:
1.Biotechnology
- CRISPR/Cas9 genome editing technology
- Plant biotechnology and its potential applications
- Synthetic biology: designing and creating new biological systems ...
2.Biomedicine
- Advances in precision medicine
- Novel therapeutic targets and drug development
- Genetic basis of disease and personalized treatment ...
All accepted full papers will be published by BIO Web of Conferences (ISSN: 2117-4458) and will be submitted to Scopus for indexing.
For More Details please visit:
https://ais.cn/u/Fzeqau
Other CFPs
- 20th International Conference on Information Systems Security
- Clinical Use of Blood Biomarkers in the Era of Disease Modifying Treatments for Early Symptomatic Alzheimer’s Disease
- Psychedelic Therapy: Is the Future of Mental Healthcare Finally Here?
- Benefits of Utilizing Early Precision QT and Artificial Intelligence-Powered Data Quality Assessments in Early Phase Trials
- Transform Customer Engagement with NextGen Above-Brand Capabilities
Last modified: 2024-01-30 12:30:10